New nasal spray shows promise for tough brain tumors
Disease control
Recruiting now
This study tests an experimental drug called NEO100 (perillyl alcohol) in people whose aggressive brain tumors (grade III or IV gliomas with an IDH1 mutation) have come back or worsened. The drug is taken as a nasal spray four times a day. The first part finds the safest dose, an…
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 03, 2026 01:59 UTC